The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Rheumatoid Arthritis–Interstitial Lung Disease–associated Mortality
Open accessAbstract
RATIONALE: Mortality rates from rheumatoid arthritis-associated interstitial lung disease (RA-ILD) are largely unknown. OBJECTIVES: We sought to determine mortality rates from rheumatoid arthritis-associated interstitial lung disease in the United States from 1988 through 2004. METHODS: Using data from the National Center for Health Statistics, we calculated age-adjusted mortality rates from the deaths of persons with rheumatoid arthritis-associated interstitial lung disease, determined the prevalence of interstitial lung disease in all decedents with rheumatoid arthritis, and compared the age and underlying cause of death in these two cohorts of decedents. MEASUREMENTS AND MAIN RESULTS: From 1988 to 2004, there were 39,138,394 deaths in U.S. residents and 162,032 rheumatoid arthritis-associated deaths. Of these deaths, 10,725 (6.6%) met criteria for rheumatoid arthritis-associated interstitial lung. Mortality rates from rheumatoid arthritis fell over the course of this study in both women and men. However, mortality rates from rheumatoid arthritis-associated interstitial lung disease increased 28.3% in women (to 3.1 per million persons in 2004) and declined 12.5% in men (to 1.5 per million persons in 2004). Because the rate of decline in rheumatoid arthritis outpaced rheumatoid arthritis-associated interstitial lung disease in men, the prevalence of rheumatoid arthritis-associated interstitial lung disease increased in both sexes over time. CONCLUSIONS: Clinically significant RA-ILD occurs in nearly 10% of the RA population, and is associated with shortened survival and more severe underlying disease. Whereas overall mortality rates for RA have fallen, those associated with RA-ILD have increased significantly in older age groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Bowman, P. W. (1963) · AIBS Bulletin · doi:10.2307/1292957 · Cited by 3,638
The epidemiology of interstitial lung diseases.
Coultas, D. B., Zumwalt, R. E., Black, W. C., & Sobonya, R. E. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.4.7921471 · Cited by 946
Bongartz, T., Nannini, C., Medina‐Velasquez, Y. F., Achenbach, S. J., Crowson, C. S., Ryu, J. H., Vassallo, R., Gabriel, S. E., & Matteson, E. L. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27405 · Cited by 864
THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS
Gabriel, S. E. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70201-5 · Cited by 782
Autoimmune Diseases Induced by TNF-Targeted Therapies: Analysis of 233 Cases
Ramos-Casals, M., Brito-Zerón, P., Muñoz, S., Soria, N., Galiana, D., Bertolaccini, L., Cuadrado, M.-J., & Khamashta, M. A. (2007) · Medicine · doi:10.1097/md.0b013e3181441a68 · Cited by 733
Turesson, C., O'Fallon, W. M., Crowson, C. S., Gabriel, S. E., & Matteson, E. L. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.8.722 · Cited by 672
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Self-citationPark, J. H., Kim, D. S., Park, I.-N., Jang, S. J., Kitaichi, M., Nicholson, A. G., & Colby, T. V. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-912oc · Cited by 597
Interstitial Lung Disease in Recent Onset Rheumatoid Arthritis
GABBAY, E., TARALA, R., WILL, R., CARROLL, G., ADLER, B., CAMERON, D., & LAKE, F. R. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9609016 · Cited by 451
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
Olson, A. L., Swigris, J. J., Lezotte, D. C., Norris, J. M., Wilson, C. G., & Brown, K. K. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-044oc · Cited by 435
Self-citationThe epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985
Gabriel, S. E., Crowson, C. S., & O'Fallon, M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:3<415::aid-anr4>3.0.co;2-z · Cited by 359
Ledingham, J., Deighton, C., & on behalf of the British Society for Rheumatology Standards, G. A. A. W. G. (2005) · Rheumatology · doi:10.1093/rheumatology/keh464 · Cited by 331
Roger S. Mitchell Lecture. Rheumatoid Lung Disease
Brown, K. K. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200703-045ms · Cited by 196
Self-citation3. Sampling variance of standardized mortality rates.
Keyfitz, N. (1966) · PubMed · Cited by 149
Björnådal, L., Baecklund, E., Yin, L., Granath, F., Klareskog, L., & Ekbom, A. (2002) · PubMed · Cited by 130
Rising mortality from cryptogenic fibrosing alveolitis.
Johnston, I., Britton, J. R., Kinnear, W. J. M., & Logan, R. (1990) · BMJ · doi:10.1136/bmj.301.6759.1017 · Cited by 119
A Comparison of Underlying Cause and Multiple Causes of Death
Redelings, M. D., Sorvillo, F. J., & Simon, P. A. (2005) · Epidemiology · doi:10.1097/01.ede.0000187177.96138.c6 · Cited by 110
Lynch, J. P., Wurfel, M. M., Flaherty, K. R., et al. (2001) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2001-17381 · Cited by 58
Lynch, J. P., Saggar, R., Weigt, S., et al. (2006) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2006-957335 · Cited by 40
Cited by
Cottin, V., Hirani, N. A., Hotchkin, D. L., Nambiar, A. M., Ogura, T., Otaola, M., Skowasch, D., Park, J. S., Poonyagariyagorn, H. K., Wuyts, W., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0076-2018 · Cited by 652
Kelly, C. A., Saravanan, V., Nisar, M., Arthanari, S., Woodhead, F. A., Price-Forbes, A. N., Dawson, J., Sathi, N., Ahmad, Y., Koduri, G., et al. (2014) · Rheumatology · doi:10.1093/rheumatology/keu165 · Cited by 549
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
Juge, P.-A., Lee, J. S., Ebstein, E., Furukawa, H., Dobrinskikh, E., Gazal, S., Kannengiesser, C., Ottaviani, S., Oka, S., Tohma, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801562 · Cited by 520
Self-citationHyldgaard, C., Hilberg, O., Pedersen, A. B., Ulrichsen, S. P., Løkke, A., Bendstrup, E., & Ellingsen, T. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211138 · Cited by 476
Hutchinson, J. P., Fogarty, A. W., McKeever, T. M., & Hubbard, R. B. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1632oc · Cited by 440
Metadata
- Authors
- Olson, A. L., Swigris, J. J., Sprunger, D. B., Fischer, A., Fernandez-Perez, E. R., Solomon, J., Murphy, J., Cohen, M., Raghu, G., & Brown, K. K.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-01
- Volume
- 183
- Issue
- 3
- Pages
- 372-378
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2106501933
- Cited by
- 544
- References
- 21
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.